Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
Year: 2020
Type: review
Abstract: Rapid spread of coronavirus disease 2019 (COVID-19) is ravaging the globe. Since its first report in December 2019, COVID-19 cases have exploded to over 14 million as of July 2020, claiming more than 600,000 lives. Implementing fast and widespread diagnostic tests is paramount to contain COVID-19, given the current lack of an effective therapeutic or vaccine. This review focuses on a broad description of currently available diagnostic tests to detect either the virus (SARS-CoV-2) or virus-induced immune responses. We specifically explain the working mechanisms of these tests and compare their analytical performance. These analyses will assist in selecting most effective tests for a given application, for example, epidemiology or global pandemic research, population screening, hospital-based testing, home-based and point-of-care testing, and therapeutic trials. Finally, we lay out the shortcomings of certain tests and future needs.
Source: iScience
Authors: Tugba Kilic, Ralph Weissleder, Hakho Lee
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,000
Awards: ARTIFICIAL INTELLIGENCE-BASED DIFFRACTION ANALYSIS (AIDA) FOR POINT-OF-CARE BREAST CANCER CLASSIFICATION, Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics, EARLY DETECTION OF LUNG CANCER THROUGH MOLECULAR ANALYSES OF SINGLE EXTRACELLULAR VESICLES, High-throughput Integrated Magneto-electrochemical Exosome (HiMEX) platform to identify neurodevelopmental markers associated with pre and postnatal oxycodone exposure, Clinical platform for high-throughput analyses of extracellular vesicles
OpenAlex ID: W3043879196
